For: | Chu YD, Chen CW, Lai MW, Lim SN, Lin WR. Bioenergetic alteration in gastrointestinal cancers: The good, the bad and the ugly. World J Gastroenterol 2023; 29(29): 4499-4527 [PMID: 37621758 DOI: 10.3748/wjg.v29.i29.4499] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v29/i29/4499.htm |
Number | Citing Articles |
1 |
Fernanda Santos Thomaz, Oliver Dean John, Payel Sinha, Siti Raihanah Shafie, Simon Worrall. The Metabolic Syndrome: An Overview and Proposed Mechanisms. Obesities 2024; 4(3): 226 doi: 10.3390/obesities4030020
|
2 |
Ashwani Sharma, Tarun Virmani, Girish Kumar, Anjali Sharma, Reshu Virmani, Dalapathi Gugulothu, Kuldeep Singh, Shashi Kiran Misra, Kamla Pathak, Nitin Chitranshi, Henrique Douglas Melo Coutinho, Divya Jain. Mitochondrial signaling pathways and their role in cancer drug resistance. Cellular Signalling 2024; 122: 111329 doi: 10.1016/j.cellsig.2024.111329
|
3 |
Nayeralsadat Fatemi, Mina Karimpour, Hoda Bahrami, Mohammad Reza Zali, Vahid Chaleshi, Andrea Riccio, Ehsan Nazemalhosseini-Mojarad, Mehdi Totonchi. Current trends and future prospects of drug repositioning in gastrointestinal oncology. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1329244
|
4 |
Na Liu, Jianzeng Zhang, Jiaojiao Wu, Fan Feng, Yantao Chai, Yongwu Li, Bo Liu. Targeting hepatocellular carcinoma growth and metabolism: A synergistic approach with para-toluenesulfonamide and radiofrequency ablation. iLIVER 2024; 3(3): 100111 doi: 10.1016/j.iliver.2024.100111
|